I Saldi Cambiamento Data
AbbVie USD 17.4B 410M 2026-09
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amgen USD 10.4B 300M 2026-09
Arrowhead Research USD 450.82M 375.59M 2026-09
Astellas Pharma JPY 629.95B 10.96B 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Bayer EUR 10.05B 820M 2026-09
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Daiichi Sankyo JPY 592.49B 17.75B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Exelixis USD 658.69M 30M 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Merck USD 18.1B 1.5B 2026-09
Moderna USD 1.31M 98.69M 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.52B 112M 2026-09
Novartis USD 15.03B 1.92B 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09